Results 1 to 10 of about 361,533 (204)

Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 1: Developing and delivering high-quality independent clinical trials [PDF]

, 2022
The UK Dermatology Clinical Trials Network (UK DCTN) was formed in 2002 with the aim of developing and supporting high-quality independent national clinical trials that address prioritized research questions for people with skin disease.
UK Dermatology Clinical Trials Network, McPhee, Margaret, McPhee, Margaret J, Layfield, Carron P, Sach, Tracey, Layfield, Carron, Williams, Hywel C, The UK Dermatology Clinical Trials Network, Williams, Hywel C.   +8 more
core   +2 more sources

General dermatology and dermatology in primary healthcare

Clinical and Experimental Dermatology
A woman in her 40s with recurrent urticarial-like rash, low-grade fever, fatigue and lower limb pain was diagnosed with Schnitzler syndrome after laboratory results revealed elevated inflammatory markers and monoclonal IgM gammopathy. Histopathology showed neutrophilic infiltrates, and imaging identified osteosclerotic lesions.
Bučić, Dinea, Darcis, Gilles, El Moussaoui, Majdouline   +2 more
  +27 more sources

Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 2: education, training and capacity building [PDF]

, 2022
In Part 1 of this 2-part review of the 20th anniversary of the UK Dermatology Clinical Trials Network (UK DCTN), we described its role in developing and supporting clinical trial proposals, elaborating on structure, process and clinical trials activity ...
Layfield, Carron P., The UK Dermatology Clinical Trials Network, Williams, Hywel C.   +2 more
core   +2 more sources

Vaccine considerations for adult dermatology patients on immunosuppressive and immunomodulatory therapies: a clinical review [PDF]

, 2021
Adults with chronic inflammatory skin disease are at increased risk of vaccine-preventable illnesses and infections, likely because of the underlying disease itself and also their treatment with immunosuppressive and immunomodulatory medications. Despite
Noe, Megan H, Tan, Alice J., Noe, Megan H., Merola, Joseph F, Streicher, Jenna L., Merola, Joseph F., Tan, Alice J, Streicher, Jenna L   +7 more
core   +1 more source

Defining patient-centered research priorities in pediatric dermatology [PDF]

, 2022
Background/objectives: Patient and caregiver perspectives are critical in understanding dermatologic disease impact, presentation, and management in children.
Rittle, James, Camp, Karen, Siegel, Michael, Quinn, Paula, Neale, Holly, Devenport, Katherine, Pry, Sarah, Terrell, Julia, Hall, Michelle, Abbott, Becky M, Weiss, Meredith, Austin, Jennifer, Zavitz, Sam, Tenconi, Francesca, Isbell, Lauren, Schrandt, Suz, Brand, Callista, Miciano, Charlene   +17 more
core   +2 more sources

Avoidable research waste in dermatology: what are the solutions? [PDF]

, 2022
In the last editorial, I provided examples of research waste in dermatology and suggested that it was due to a system failure rather than just a few “bad apples”.
Williams, Hywel C, Williams, H. C.
core   +2 more sources

DERMATOLOGY [PDF]

The American Journal of the Medical Sciences, 1886
n ...
LOUIS A. DUHRING, HENRY W. STELWAGON
openaire   +2 more sources

Cost Minimization Analysis of a Teledermatology Triage System in a Managed Care Setting [PDF]

, 2021
Importance: Teledermatology (TD) enables remote triage and management of dermatology patients. Previous analyses of TD systems have demonstrated improved access to care but an inconsistent fiscal impact.
Amerson, Erin, Zakaria, Adam, Maurer, Toby, Miclau, Theodore A., Leslie, Kieron S.   +4 more
core   +1 more source

Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting [PDF]

, 2020
Background: The Harmonising Outcome Measures for Eczema (HOME) initiative has established a core outcome set of domains for atopic eczema (AE) clinical trials. Previous consensus meetings have agreed on preferred instruments for clinician-reported signs (
Gerbens, L. A. A., Gadkari, A., Grinich, E, Eckert, L., Stuart, B. L., Nakahara, T., Katoh, N, Howie, L., Williams, HC, Burton, T, Gerbens, LAA, Nakahara, T, Apfelbacher, CA, Gerbens, L.A.A., Howie, L, Eckert, L, Apfelbacher, C. A., Spuls, PI, Thomas, K. S., Thomas, K.S., Simpson, E., Burton, T., Grinich, E., Schmitt, J., Howells, L, Pawlitschek, T, Chalmers, J.R., Spuls, P.I., Ebata, T., Katoh, N., Boers, M., Chalmers, JR, Williams, H. C., Schmitt, J, Gadkari, A, Howells, L., Chalmers, J. R., Boers, M, Stuart, B.L., Simpson, E, Saeki, H., Ebata, T, Apfelbacher, C.A., Gabes, M, Pawlitschek, T., Spuls, P. I., Saeki, H, Gabes, M., Stuart, BL, Thomas, KS   +49 more
core   +2 more sources

Mapping the undergraduate dermatology curriculum – a useful tool towards implementation of national recommendations [PDF]

, 2020
Despite the high prevalence of skin complaints in primary and secondary care, dermatology undergraduate (UG) education remains inconsistent across medical schools. The British Association of Dermatologists (BAD) published a revised national undergraduate
Doody, G., Murphy, R., Scorer, M., Kent, D., Sharma, M.   +4 more
core   +1 more source